Structural Mapping of Na1.7 Antagonists

Overview

Journal Nat Commun

Specialty Biology

Date 2023 Jun 3

PMID 37270609

Authors

Qiurong Wu

Jian Huang

Xiao Fan

Kan Wang

Xueqin Jin

Gaoxingyu Huang

Jiaao Li

Xiaojing Pan

Nieng Yan

Affiliations

Soon will be listed here.

Abstract

Voltage-gated sodium (Na) channels are targeted by a number of widely used and investigational drugs for the treatment of epilepsy, arrhythmia, pain, and other disorders. Despite recent advances in structural elucidation of Na channels, the binding mode of most Na-targeting drugs remains unknown. Here we report high-resolution cryo-EM structures of human Na1.7 treated with drugs and lead compounds with representative chemical backbones at resolutions of 2.6-3.2 Å. A binding site beneath the intracellular gate (site BIG) accommodates carbamazepine, bupivacaine, and lacosamide. Unexpectedly, a second molecule of lacosamide plugs into the selectivity filter from the central cavity. Fenestrations are popular sites for various state-dependent drugs. We show that vinpocetine, a synthetic derivative of a vinca alkaloid, and hardwickiic acid, a natural product with antinociceptive effect, bind to the III-IV fenestration, while vixotrigine, an analgesic candidate, penetrates the IV-I fenestration of the pore domain. Our results permit building a 3D structural map for known drug-binding sites on Na channels summarized from the present and previous structures.

Citing Articles

Voltage-gated sodium channels in excitable cells as drug targets.

Alsaloum M, Dib-Hajj S, Page D, Ruben P, Krainer A, Waxman S Nat Rev Drug Discov. 2025; .

PMID: 39901031 DOI: 10.1038/s41573-024-01108-x.

Discovery of Novel Na1.7-Selective Inhibitors with the 1-Indole-3-Propionamide Scaffold for Effective Pain Relief.

Wang G, Wu H, Wang Y, Liu X, Peng S, Wang W Research (Wash D C). 2025; 8:0599.

PMID: 39881860 PMC: 11775380. DOI: 10.34133/research.0599.

Drugs exhibit diverse binding modes and access routes in the Nav1.5 cardiac sodium channel pore.

Tao E, Corry B J Gen Physiol. 2025; 157(2).

PMID: 39774837 PMC: 11706274. DOI: 10.1085/jgp.202413658.

Molecular determinants of resurgent sodium currents mediated by Navβ4 peptide and A-type FHFs.

Xiao Y, Pan Y, Xiao J, Cummins T Front Mol Neurosci. 2024; 17:1433981.

PMID: 39416265 PMC: 11480954. DOI: 10.3389/fnmol.2024.1433981.

Tuning Sodium Channel Blockers to the Near-Atomic Level.

Eyal S Epilepsy Curr. 2024; 24(2):123-125.

PMID: 39280048 PMC: 11394411. DOI: 10.1177/15357597231225065.

References

Ahuja S, Mukund S, Deng L, Khakh K, Chang E, Ho H . Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist. Science. 2015; 350(6267):aac5464. DOI: 10.1126/science.aac5464. View

Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

Bende N, Dziemborowicz S, Mobli M, Herzig V, Gilchrist J, Wagner J . A distinct sodium channel voltage-sensor locus determines insect selectivity of the spider toxin Dc1a. Nat Commun. 2014; 5:4350. PMC: 4115291. DOI: 10.1038/ncomms5350. View

Zhao Y, Huang G, Wu J, Wu Q, Gao S, Yan Z . Molecular Basis for Ligand Modulation of a Mammalian Voltage-Gated Ca Channel. Cell. 2019; 177(6):1495-1506.e12. DOI: 10.1016/j.cell.2019.04.043. View

Dib-Hajj S, Yang Y, Black J, Waxman S . The Na(V)1.7 sodium channel: from molecule to man. Nat Rev Neurosci. 2012; 14(1):49-62. DOI: 10.1038/nrn3404. View

Fertleman C, Baker M, Parker K, Moffatt S, Elmslie F, Abrahamsen B . SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron. 2006; 52(5):767-74. DOI: 10.1016/j.neuron.2006.10.006. View

Wisedchaisri G, Tonggu L, Gamal El-Din T, McCord E, Zheng N, Catterall W . Structural Basis for High-Affinity Trapping of the Na1.7 Channel in Its Resting State by Tarantula Toxin. Mol Cell. 2020; 81(1):38-48.e4. PMC: 8043720. DOI: 10.1016/j.molcel.2020.10.039. View

Yang Y, Huang C, Kuo C . Lidocaine, carbamazepine, and imipramine have partially overlapping binding sites and additive inhibitory effect on neuronal Na+ channels. Anesthesiology. 2010; 113(1):160-74. DOI: 10.1097/ALN.0b013e3181dc1dd6. View

Huang J, Fan X, Jin X, Jo S, Zhang H, Fujita A . Cannabidiol inhibits Na channels through two distinct binding sites. Nat Commun. 2023; 14(1):3613. PMC: 10276812. DOI: 10.1038/s41467-023-39307-6. View

10.

Grant T, Grigorieff N . Measuring the optimal exposure for single particle cryo-EM using a 2.6 Å reconstruction of rotavirus VP6. Elife. 2015; 4:e06980. PMC: 4471936. DOI: 10.7554/eLife.06980. View

11.

Smart O, Neduvelil J, Wang X, Wallace B, Sansom M . HOLE: a program for the analysis of the pore dimensions of ion channel structural models. J Mol Graph. 1996; 14(6):354-60, 376. DOI: 10.1016/s0263-7855(97)00009-x. View

12.

Shen H, Zhou Q, Pan X, Li Z, Wu J, Yan N . Structure of a eukaryotic voltage-gated sodium channel at near-atomic resolution. Science. 2017; 355(6328). DOI: 10.1126/science.aal4326. View

13.

Legros C, Ceard B, Vacher H, Marchot P, Bougis P, Martin-Eauclaire M . Expression of the standard scorpion alpha-toxin AaH II and AaH II mutants leading to the identification of some key bioactive elements. Biochim Biophys Acta. 2005; 1723(1-3):91-9. DOI: 10.1016/j.bbagen.2005.01.008. View

14.

Chernov-Rogan T, Li T, Lu G, Verschoof H, Khakh K, Jones S . Mechanism-specific assay design facilitates the discovery of Nav1.7-selective inhibitors. Proc Natl Acad Sci U S A. 2018; 115(4):E792-E801. PMC: 5789920. DOI: 10.1073/pnas.1713701115. View

15.

Catterall W, Goldin A, Waxman S . International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev. 2005; 57(4):397-409. DOI: 10.1124/pr.57.4.4. View

16.

Yang Y, Wang Y, Li S, Xu Z, Li H, Ma L . Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet. 2004; 41(3):171-4. PMC: 1735695. DOI: 10.1136/jmg.2003.012153. View

17.

Clairfeuille T, Cloake A, Infield D, Llongueras J, Arthur C, Li Z . Structural basis of α-scorpion toxin action on Na channels. Science. 2019; 363(6433). DOI: 10.1126/science.aav8573. View

18.

Zhang X, Ren W, Decaen P, Yan C, Tao X, Tang L . Crystal structure of an orthologue of the NaChBac voltage-gated sodium channel. Nature. 2012; 486(7401):130-4. PMC: 3979295. DOI: 10.1038/nature11054. View

19.

Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W . Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des. 2013; 27(3):221-34. DOI: 10.1007/s10822-013-9644-8. View

20.

Zhang K . Gctf: Real-time CTF determination and correction. J Struct Biol. 2015; 193(1):1-12. PMC: 4711343. DOI: 10.1016/j.jsb.2015.11.003. View